Cara Therapeutics | CARA - Interest Income


Cara Therapeutics reported $347K in Interest Income for its fiscal quarter ending in March of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.25M 1M Sep/2025
Cara Therapeutics USD 347K 74K Mar/2025
Cassava Sciences USD 1.17M 47K Sep/2025
Chugai Pharma JPY 480M 465M Jun/2024
Compugen USD 954K 116K Sep/2025
CSL USD 18M 1000K Dec/2024
J&J USD 2.12 0.17 Sep/2025
Pacira USD 8.53M 3.53M Sep/2025
Pfizer USD 0.62 156M Sep/2025
RedHill Biopharma USD 7.1M 14.49M Jun/2023
Supernus Pharmaceuticals USD 2.28M 2.25M Sep/2025